Structure Therapeutics Inc (GPCR)
37.76
+1.39
(+3.82%)
USD |
NASDAQ |
Nov 14, 16:00
37.80
+0.04
(+0.11%)
After-Hours: 20:00
Structure Therapeutics Cash and Short Term Investments (Quarterly): 927.12M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 927.12M |
| March 31, 2024 | 436.45M |
| December 31, 2023 | 467.32M |
| September 30, 2023 | 205.42M |
| June 30, 2023 | 224.59M |
| Date | Value |
|---|---|
| March 31, 2023 | 240.86M |
| December 31, 2022 | 90.84M |
| September 30, 2022 | 102.75M |
| December 31, 2021 | 107.31M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
90.84M
Minimum
Dec 2022
927.12M
Maximum
Jun 2024
311.41M
Average
224.59M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Viking Therapeutics Inc | 930.44M |
| Eli Lilly and Co | 3.518B |
| Novo Nordisk AS | 11.22B |
| Pfizer Inc | 9.952B |
| Amgen Inc | 9.011B |